Cargando…

Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice

Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tunisi, Lea, D'Angelo, Livia, Fernández-Rilo, Alba Clara, Forte, Nicola, Piscitelli, Fabiana, Imperatore, Roberta, de Girolamo, Paolo, Di Marzo, Vincenzo, Cristino, Luigia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890184/
https://www.ncbi.nlm.nih.gov/pubmed/33613258
http://dx.doi.org/10.3389/fnsyn.2021.622405
_version_ 1783652462706556928
author Tunisi, Lea
D'Angelo, Livia
Fernández-Rilo, Alba Clara
Forte, Nicola
Piscitelli, Fabiana
Imperatore, Roberta
de Girolamo, Paolo
Di Marzo, Vincenzo
Cristino, Luigia
author_facet Tunisi, Lea
D'Angelo, Livia
Fernández-Rilo, Alba Clara
Forte, Nicola
Piscitelli, Fabiana
Imperatore, Roberta
de Girolamo, Paolo
Di Marzo, Vincenzo
Cristino, Luigia
author_sort Tunisi, Lea
collection PubMed
description Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexinergic LH output area with functional effects on dopaminergic signaling at the mesolimbic circuit. By confocal and correlative light and electron microscopy (CLEM) morphological studies coupled to molecular, biochemical, and pharmacological approaches, we investigated OX-A-mediated dopaminergic signaling at the LH-VTA-nucleus accumbens (NAc) pathway in obese ob/ob mice compared to wild-type (wt) lean littermates. We found an elevation of OX-A trafficking and release to the VTA of ob/ob mice and consequent orexin receptor-1 (OX1R)-mediated over-activation of dopaminergic (DA) neurons via phospholipase C (PLC)/diacylglycerol lipase (DAGL-α)-induced biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). In fact, by retrograde signaling to cannabinoid receptor type 1 (CB1R) at inhibitory inputs to DA neurons, 2-AG inhibited GABA release thus inducing an increase in DA concentration in the VTA and NAc of ob/ob mice. This effect was prevented by the OX1R antagonist SB-334867 (30 mg/Kg, i.p.), or the CB1R antagonist AM251 (10 mg/Kg, i.p.) and mimicked by OX-A injection (40 μg/Kg, i.p.) in wt lean mice. Enhanced DA signaling to the NAc in ob/ob mice, or in OX-A-injected wt mice, was accompanied by β-arrestin2-mediated desensitization of dopamine D2 receptor (D2R) in a manner prevented by SB-334867 or the D2R antagonist L741 (1.5 mg/Kg, i.p.). These results further support the role of OX-A signaling in the control of neuroadaptive responses, such as compulsive reward-seeking behavior or binge-like consumption of high palatable food, and suggest that aberrant OX-A trafficking to the DA neurons in the VTA of ob/ob mice influences the D2R response at NAc, a main target area of the mesolimbic pathway, via 2-AG/CB1-mediated retrograde signaling.
format Online
Article
Text
id pubmed-7890184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78901842021-02-19 Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice Tunisi, Lea D'Angelo, Livia Fernández-Rilo, Alba Clara Forte, Nicola Piscitelli, Fabiana Imperatore, Roberta de Girolamo, Paolo Di Marzo, Vincenzo Cristino, Luigia Front Synaptic Neurosci Neuroscience Disinhibition of orexin-A/hypocretin-1 (OX-A) release occurs to several output areas of the lateral hypothalamus (LH) in the brain of leptin knockout obese ob/ob mice. In this study, we have investigated whether a similar increase of OX-A release occurs to the ventral tegmental area (VTA), an orexinergic LH output area with functional effects on dopaminergic signaling at the mesolimbic circuit. By confocal and correlative light and electron microscopy (CLEM) morphological studies coupled to molecular, biochemical, and pharmacological approaches, we investigated OX-A-mediated dopaminergic signaling at the LH-VTA-nucleus accumbens (NAc) pathway in obese ob/ob mice compared to wild-type (wt) lean littermates. We found an elevation of OX-A trafficking and release to the VTA of ob/ob mice and consequent orexin receptor-1 (OX1R)-mediated over-activation of dopaminergic (DA) neurons via phospholipase C (PLC)/diacylglycerol lipase (DAGL-α)-induced biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). In fact, by retrograde signaling to cannabinoid receptor type 1 (CB1R) at inhibitory inputs to DA neurons, 2-AG inhibited GABA release thus inducing an increase in DA concentration in the VTA and NAc of ob/ob mice. This effect was prevented by the OX1R antagonist SB-334867 (30 mg/Kg, i.p.), or the CB1R antagonist AM251 (10 mg/Kg, i.p.) and mimicked by OX-A injection (40 μg/Kg, i.p.) in wt lean mice. Enhanced DA signaling to the NAc in ob/ob mice, or in OX-A-injected wt mice, was accompanied by β-arrestin2-mediated desensitization of dopamine D2 receptor (D2R) in a manner prevented by SB-334867 or the D2R antagonist L741 (1.5 mg/Kg, i.p.). These results further support the role of OX-A signaling in the control of neuroadaptive responses, such as compulsive reward-seeking behavior or binge-like consumption of high palatable food, and suggest that aberrant OX-A trafficking to the DA neurons in the VTA of ob/ob mice influences the D2R response at NAc, a main target area of the mesolimbic pathway, via 2-AG/CB1-mediated retrograde signaling. Frontiers Media S.A. 2021-02-04 /pmc/articles/PMC7890184/ /pubmed/33613258 http://dx.doi.org/10.3389/fnsyn.2021.622405 Text en Copyright © 2021 Tunisi, D'Angelo, Fernández-Rilo, Forte, Piscitelli, Imperatore, de Girolamo, Di Marzo and Cristino. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Tunisi, Lea
D'Angelo, Livia
Fernández-Rilo, Alba Clara
Forte, Nicola
Piscitelli, Fabiana
Imperatore, Roberta
de Girolamo, Paolo
Di Marzo, Vincenzo
Cristino, Luigia
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title_full Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title_fullStr Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title_full_unstemmed Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title_short Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
title_sort orexin-a/hypocretin-1 controls the vta-nac mesolimbic pathway via endocannabinoid-mediated disinhibition of dopaminergic neurons in obese mice
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890184/
https://www.ncbi.nlm.nih.gov/pubmed/33613258
http://dx.doi.org/10.3389/fnsyn.2021.622405
work_keys_str_mv AT tunisilea orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT dangelolivia orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT fernandezriloalbaclara orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT fortenicola orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT piscitellifabiana orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT imperatoreroberta orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT degirolamopaolo orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT dimarzovincenzo orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice
AT cristinoluigia orexinahypocretin1controlsthevtanacmesolimbicpathwayviaendocannabinoidmediateddisinhibitionofdopaminergicneuronsinobesemice